These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16567664)
1. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Scott PA; Silbergleit R Stroke; 2006 Apr; 37(4):943-4; author reply 944. PubMed ID: 16567664 [No Abstract] [Full Text] [Related]
2. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Demaerschalk BM; Yip TR Stroke; 2005 Nov; 36(11):2500-3. PubMed ID: 16224087 [TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke. Leppert MH; Campbell JD; Simpson JR; Burke JF Stroke; 2015 Jul; 46(7):1870-6. PubMed ID: 26012639 [TBL] [Abstract][Full Text] [Related]
4. Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke. Berkowitz AL; Mittal MK; McLane HC; Shen GC; Muralidharan R; Lyons JL; Shinohara RT; Shuaib A; Mateen FJ Int J Stroke; 2014 Apr; 9(3):349-55. PubMed ID: 24207029 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center. Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519 [TBL] [Abstract][Full Text] [Related]
17. Current indications and results of thrombolysis by intravenous recombinant tissue plasminogen activator. Tari Capone F; Cavallari M; Casolla B; Orzi F Tech Vasc Interv Radiol; 2012 Mar; 15(1):10-8. PubMed ID: 22464298 [TBL] [Abstract][Full Text] [Related]
18. Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada. Yip TR; Demaerschalk BM Stroke; 2007 Jun; 38(6):1952-5. PubMed ID: 17478740 [TBL] [Abstract][Full Text] [Related]